Abstract 124P
Background
The prevalence of hepatocellular carcinoma (HCC) is increasing worldwide. We performed this study to understand the clinical profile and survival outcomes and prognostic factors of HCC patients in India.
Methods
This is a retrospective study, conducted at the Department of Medical Oncology, Madras Medical College, Chennai, India. The records of all patients diagnosed to have HCC as per the EASL criteria, referred to our department between January 2018 and June 2020 were collected. The data were analysed with IBM SPSS Statistics for Windows, Version 23.0.
Results
125 patients with HCC were referred to the Department of Medical Oncology out of which the data of 116 patients were analysed. The mean age at presentation was 58 years. The patients were predominantly males (95% cases). The most common aetiology was alcoholic liver disease (82% cases). None of the patients were diagnosed on routine surveillance. The most common presenting symptoms were loss of weight and loss of appetite (n=102,88%). Majority of the patients belonged to CTP class B(n=54,46.5%). Most of the patients belonged to BCLC stage C(n=60, 51%). Treatment given was as follows: Surgical Resection (n=9, 8%), TACE (n=12,10%), sorafenib (n= 60, 52 %), Best supportive care (n=35, 30%). The median OS was 5.1 months. A significant association was seen between BCLC stage and OS (median OS in stage 0, A, B, C and D being 37, 22, 12, 5.5 and 2 months, respectively, p =<0.0001). The median OS was significantly associated with CTP class (8 months in CTP A, 5.5 months in CTP B and 2.0 months in CTP C,p =0.047).The patients grouped into BCLC C demonstrated a similar overall survival, irrespective of the CTP class (5.5 vs 6 months in CTP A and B respectively, p=0.628).
Conclusions
Alcoholic liver disease was found to be the most common cause of HCC. BCLC stage and CTP were found to be prognostic in terms of OS. As patients belonging to BCLC C had a similar OS irrespective of CTP class, future trials evaluating newer therapies in BCLC C patients may include CTP B patients in good numbers, rather than under-representing them. Most of the patients are detected at a late stage (BCLC C being most common), precluding curative therapies. Improved access to primary health care is the need of the hour.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
108P - A meta-analysis of PD-1 inhibitors for the treatment of advanced esophageal squamous cell carcinoma in second-line setting
Presenter: Barinder Singh
Session: Poster viewing 02
109P - Economic evaluation of second-line treatment for patients with esophageal squamous cell carcinoma: A systematic review
Presenter: Gagandeep Kaur
Session: Poster viewing 02
110P - Neutrophil to lymphocyte ratio as a predictor of poor prognosis in advanced esophageal cancer
Presenter: Chaichana Chantharakhit
Session: Poster viewing 02
111P - Bicentric real-life analysis of the molecular portrait of patients with early onset metastatic biliary tract cancer
Presenter: Theresa Schmalfuss
Session: Poster viewing 02
112P - Prognostic role of sarcopenia before neoadjuvant chemoradiotherapy in patients with esophageal cancer: A retrospective study
Presenter: Mastaneh Sanei
Session: Poster viewing 02
113P - Brain metastases in esophageal cancer patients who have been treated with neoadjuvant immunotherapy plus chemotherapy: An inconsiderable complication
Presenter: Jun Liu
Session: Poster viewing 02
114P - Risk factors for oesophageal fistula: A life-threatening complication of treatment for oesophageal cancer
Presenter: Reo Omori
Session: Poster viewing 02
115P - Human epidermal growth factor receptor-2 (HER-2) expression status in patients with cholangiocarcinoma
Presenter: Thanit Imemkamon
Session: Poster viewing 02
116P - Spleen as an organ at risk (OAR) in adjuvant chemoradiotherapy of gastric cancer: Retrospective dosimetric single institutional experience
Presenter: Preethi Shetty
Session: Poster viewing 02
117P - Immunoprofile of adenosquamous carcinoma in gastric cancer
Presenter: Cheng-Han Wu
Session: Poster viewing 02